Evidence map›Paper›PMID 37740403›Full record

ArticleHuman molecular genetics2023

Investigation of common genetic risk factors between thyroid traits and breast cancer.

Elise A Lucotte, Yazdan Asgari, Pierre-Emmanuel Sugier, Mojgan Karimi, Cloé Domenighetti, Fabienne Lesueur, Anne Boland-Augé, Evgenia Ostroumova, Florent de Vathaire, Monia Zidane and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. PeerJ · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Elise A LucotteParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Yazdan AsgariParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Pierre-Emmanuel SugierParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Mojgan KarimiParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Cloé DomenighettiParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Fabienne LesueurInserm, U900, Institut Curie, PSL University, Mines ParisTech, 75006 Paris, France.
Anne Boland-AugéNational Centre of Human Genomics Research, François Jacob Institute of Biology, Commissariat à l'Energie Atomique, Paris-Saclay University, 91000 Evry, France.
Evgenia OstroumovaInternational Agency for Research on Cancer, WHO, 69007 Lyon, France.
Florent de VathaireParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team of Epidemiology of radiations, 94807 Villejuif, France.
Monia ZidaneParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team of Epidemiology of radiations, 94807 Villejuif, France.
Pascal GuénelParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Jean-François DeleuzeNational Centre of Human Genomics Research, François Jacob Institute of Biology, Commissariat à l'Energie Atomique, Paris-Saclay University, 91000 Evry, France.
Marie-Christine Boutron-RuaultParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Gianluca SeveriParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Benoît LiquetLaboratoire de Mathématiques et de leurs Applications de Pau, Université de Pau et des Pays de l'Adour, UMR CNRS 5142, E2S-UPPA, 64013 Pau, France.
Thérèse TruongParis-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
Université Paris-Saclay · FRInserm · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FRCentre de recherche en Epidémiologie et Santé des Populations · FRCentre international de recherche sur le cancer · FRLaboratoire de Mathématiques et de leurs Applications · FR

Funding

Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Cancer Research UK C1287/A10118Cancer Research UK C1287/A10710Cancer Research UK C1287/A16563NCI NIH HHS U19 CA148065World Health Organization 001
6 · The paper itself

Abstract

Breast cancer (BC) risk is suspected to be linked to thyroid disorders, however observational studies exploring the association between BC and thyroid disorders gave conflicting results. We proposed an alternative approach by investigating the shared genetic risk factors between BC and several thyroid traits. We report a positive genetic correlation between BC and thyroxine (FT4) levels (corr = 0.13, p-value = 2.0 × 10-4) and a negative genetic correlation between BC and thyroid-stimulating hormone (TSH) levels (corr = -0.09, p-value = 0.03). These associations are more striking when restricting the analysis to estrogen receptor-positive BC. Moreover, the polygenic risk scores (PRS) for FT4 and hyperthyroidism are positively associated to BC risk (OR = 1.07, 95%CI: 1.00-1.13, p-value = 2.8 × 10-2 and OR = 1.04, 95%CI: 1.00-1.08, p-value = 3.8 × 10-2, respectively), while the PRS for TSH is inversely associated to BC risk (OR = 0.93, 95%CI: 0.89-0.97, p-value = 2.0 × 10-3). Using the PLACO method, we detected 49 loci associated to both BC and thyroid traits (p-value < 5 × 10-8), in the vicinity of 130 genes. An additional colocalization and gene-set enrichment analyses showed a convincing causal role for a known pleiotropic locus at 2q35 and revealed an additional one at 8q22.1 associated to both BC and thyroid cancer. We also found two new pleiotropic loci at 14q32.33 and 17q21.31 that were associated to both TSH levels and BC risk. Enrichment analyses and evidence of regulatory signals also highlighted brain tissues and immune system as candidates for obtaining associations between BC and TSH levels. Overall, our study sheds light on the complex interplay between BC and thyroid traits and provides evidence of shared genetic risk between those conditions.

Indexed as

Breast NeoplasmsThyroid GlandFemaleGenetic Risk ScoreHumansRisk FactorsThyrotropinThyroxineThyrotropinThyroxinebreast cancercross phenotype associationpleiotropythyroid cancerthyroid traits

Identifiers

PMID37740403
PMCPMC10729861
OpenAlexW4386979753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.